|
|
|
|
|
|
|
|
|
|
Sanofi's Breast Cancer Bet - Forbes.com
Sunday, May 31, 2009
2 comments :
I really think Parp Breast Cancer developments are getting exciting, especially the new products recently presented at ASCO, lets hope they make phase three and pass FDA regulations to be sold on the open market!
ReplyDeleteImportant to note that PARP inhibitors are in clinical trials for women with OVARIAN cancer - BRCA carriers:
ReplyDelete
"...also helped ovarian cancer patients, without the need for chemotherapy."
Subscribe to:
Post Comments
(
Atom
)
I really think Parp Breast Cancer developments are getting exciting, especially the new products recently presented at ASCO, lets hope they make phase three and pass FDA regulations to be sold on the open market!
ReplyDeleteImportant to note that PARP inhibitors are in clinical trials for women with OVARIAN cancer - BRCA carriers:
ReplyDelete"...also helped ovarian cancer patients, without the need for chemotherapy."